National HealthCare (NHC)
(Delayed Data from AMEX)
$137.13 USD
+1.44 (1.06%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $137.50 +0.37 (0.27%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for National HealthCare Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,142 | 1,086 | 1,074 | 1,028 | 996 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 1,142 | 1,086 | 1,074 | 1,028 | 996 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,084 | 1,053 | 1,023 | 979 | 944 |
Income After Depreciation & Amortization | 57 | 32 | 52 | 50 | 52 |
Non-Operating Income | 32 | -5 | 99 | 4 | 39 |
Interest Expense | 0 | 1 | 1 | 1 | 3 |
Pretax Income | 89 | 27 | 150 | 52 | 88 |
Income Taxes | 23 | 7 | 11 | 10 | 20 |
Minority Interest | -2 | -2 | 1 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 65 | 20 | 139 | 42 | 68 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 67 | 22 | 139 | 42 | 68 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 99 | 73 | 92 | 92 | 95 |
Depreciation & Amortization (Cash Flow) | 42 | 40 | 41 | 42 | 42 |
Income After Depreciation & Amortization | 57 | 32 | 52 | 50 | 52 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 15.38 | 15.45 | 15.42 | 15.37 | 15.36 |
Diluted EPS Before Non-Recurring Items | 3.39 | 2.29 | 3.93 | 3.68 | 3.76 |
Diluted Net EPS (GAAP) | 4.34 | 1.45 | 8.99 | 2.72 | 4.44 |
Fiscal Year end for National HealthCare Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 300.66 | 297.18 | 300.91 | 288.49 | 282.58 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 300.66 | 297.18 | 300.91 | 288.49 | 282.58 |
SG&A, R&D, and Dept/Amort Expenses | 278.14 | 281.51 | 280.74 | 275.39 | 268.51 |
Income After SG&A, R&D, and Dept/Amort Expenses | 22.52 | 15.67 | 20.17 | 13.10 | 14.07 |
Non-Operating Income | 14.08 | 20.08 | 16.55 | 1.00 | 8.35 |
Interest Expense | 0.00 | 0.05 | 0.06 | 0.08 | 0.09 |
Pretax Income | 36.60 | 35.71 | 36.67 | 14.03 | 22.32 |
Income Taxes | 9.49 | 9.46 | 8.70 | 3.91 | 6.41 |
Minority Interest | 0.26 | 0.04 | -0.44 | -0.27 | -0.36 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 27.11 | 26.25 | 27.96 | 10.12 | 15.92 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 26.84 | 26.21 | 28.41 | 10.39 | 16.28 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 15.56 | 15.51 | 15.49 | 15.33 | 15.32 |
Diluted EPS Before Non-Recurring Items | 1.00 | 0.97 | 0.98 | 0.83 | 0.89 |
Diluted Net EPS (GAAP) | 1.73 | 1.69 | 1.84 | 0.68 | 1.06 |